These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 28739788)
21. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies. Prybylski JP Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475 [TBL] [Abstract][Full Text] [Related]
22. Predicting effects of antibiotic combinations using MICs determined at pharmacokinetically derived concentration ratios: in vitro model studies with linezolid- and rifampicin-exposed Staphylococcus aureus. Golikova MV; Strukova EN; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA J Chemother; 2017 Oct; 29(5):267-273. PubMed ID: 28192070 [TBL] [Abstract][Full Text] [Related]
23. Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients. Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y Int J Antimicrob Agents; 2014 Sep; 44(3):242-7. PubMed ID: 25108880 [TBL] [Abstract][Full Text] [Related]
24. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935 [TBL] [Abstract][Full Text] [Related]
25. Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials. An MM; Shen H; Zhang JD; Xu GT; Jiang YY Int J Antimicrob Agents; 2013 May; 41(5):426-33. PubMed ID: 23537580 [TBL] [Abstract][Full Text] [Related]
26. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
30. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions. Cheng CN; Wu CC; Kuo CH; Wang CC; Wang JT; Lin YT; Jhang RS; Lin SW J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):466-475. PubMed ID: 32600864 [TBL] [Abstract][Full Text] [Related]
31. Effective treatment of post-spinal fusion methicillin-resistant Staphylococcus aureus vertebral osteomyelitis with linezolid in a renal-transplant patient. Yunde A; Inage K; Orita S; Yamauchi K; Suzuki M; Sakuma Y; Kubota G; Oikawa Y; Sainoh T; Sato J; Fujimoto K; Shiga Y; Abe K; Kanamoto H; Suzuki T; Takahashi K; Ohtori S BMC Res Notes; 2015 Nov; 8():708. PubMed ID: 26602090 [TBL] [Abstract][Full Text] [Related]
32. Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy. Ide T; Takesue Y; Ikawa K; Morikawa N; Ueda T; Takahashi Y; Nakajima K; Takeda K; Nishi S Int J Antimicrob Agents; 2018 May; 51(5):745-751. PubMed ID: 29425834 [TBL] [Abstract][Full Text] [Related]
34. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections. Johnson JR Clin Infect Dis; 2003 Jan; 36(2):236-7. PubMed ID: 12522761 [No Abstract] [Full Text] [Related]
35. Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective. von Dach E; Morel CM; Murthy A; Pagani L; Macedo-Vinas M; Olearo F; Harbarth S Clin Microbiol Infect; 2017 Sep; 23(9):659-666. PubMed ID: 28232163 [TBL] [Abstract][Full Text] [Related]
36. Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid. Souli M; Pontikis K; Chryssouli Z; Galani I; Giamarellou H Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):760-2. PubMed ID: 16283218 [No Abstract] [Full Text] [Related]
38. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042 [TBL] [Abstract][Full Text] [Related]
39. Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level. Sato M; Chida K; Suda T; Muramatsu H; Suzuki Y; Hashimoto H; Gemma H; Nakamura H J Infect Chemother; 2006 Aug; 12(4):185-9. PubMed ID: 16944256 [TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of linezolid in 16 infants and children in Japan. Shinjoh M; Iketani O; Watanabe K; Shimojima N; Kudo M; Yamagishi H; Shimada H; Sugita K; Takahashi T; Mori T; Hasegawa N; Iwata S J Infect Chemother; 2012 Aug; 18(4):591-6. PubMed ID: 22460827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]